Farmak’s specialists have developed L’esfal hepatoprotective drug of broad use spectrum and introduced it to the market. A new product is released in form of solution for injections.
L’esfal contains essential phospholipids (1 ml solution contains phosphatidylcholine out of soybeans 50 mg), needed to recover the structure and functions of the liver cells.
Kateryna Myrgorodska, Farmak’s Product Manager of OTC Drugs Marketing Department: “L’esfal is prescribed for the treatment of acute and chronic hepatitis, cirrhosis, fat and alcoholic liver disease, toxicosis in pregnant women and dermatological diseases.
The drug not only protects the liver from different destructive effects but recovers its affected structure. It should be noted that L’esfal may be prescribed for the children aged 12 years and older and pregnant and breast-feeding women”.
Training will start for more than 100 students who have signed up, and every student wishing to attend training sessions may join them. While attending the Eco-School, the students will gain the current knowledge about energy saving, climate changes, biodiversity, and interrelations in nature through the tabletop and active environmental games. They w...
According to “Business” magazine, JSC “Farmak” is ranked among the TOP 5 companies of Ukraine in the nomination “Strong Top Management – Dream Team”. The foundation of strong and modern business is its staff component. People, their development, professionalism are the core values of “Farmak”. “We have more than 2500 employees. We fill more than […]
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...